Amphastar Pharmaceuticals, Inc. Goodwill, Acquired During Period
Amphastar Pharmaceuticals, Inc. (AMPH) reported Goodwill, Acquired During Period of $391.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-14.
Discontinued › Notes
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2018-03-14
- Amphastar Pharmaceuticals, Inc. goodwill, acquired during period for the quarter ending 2016-12-31 was $0.00.
- Amphastar Pharmaceuticals, Inc. goodwill, acquired during period for the quarter ending 2016-09-30 was $21.00K.
- Amphastar Pharmaceuticals, Inc. goodwill, acquired during period for the quarter ending 2016-06-30 was -$74.00K.
- Amphastar Pharmaceuticals, Inc. goodwill, acquired during period for the quarter ending 2016-03-31 was $444.00K.
- Amphastar Pharmaceuticals, Inc. goodwill, acquired during period for fiscal 2016 was $391.00K.
- Amphastar Pharmaceuticals, Inc. goodwill, acquired during period for fiscal 2014 was $4.37M.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $21.00K derived: sum of 2 quarters · filed 2018-03-14 | -$53.00K derived: sum of 3 quarters · filed 2018-03-14 | $391.00K 10-K · filed 2018-03-14 |
| 2016-09-30 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$53.00K derived: sum of 2 quarters · filed 2016-11-09 | $391.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | -$74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $370.00K 10-Q · filed 2016-08-09 | ||
| 2016-03-31 | $444.00K 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | $4.37M 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |